Missed the live webinar? Catch the recording by clicking on the link below

Trends in Fibrosis Research and and Drug Discovery: NASH Webinar

Brought to you by The Scientist magazine and sponsored by Cisbio

This webinar features key opinion leaders in Nonalcoholic Steatohepatitis (NASH) and includes discussion of:

  • Current views on NASH etiology and the best approaches for drug-discovery efforts
  • Diagnosis and tracking NASH-induced diseases with noninvasive biomarkers
  • Targeting the Liver X Receptor (LXR) and its promiscuous activities

Want to advance your research in drug discovery and characterization of molecular interaction?

Cisbio bioassays can be used to:

Study GPCR binding and signalling (Gs, Gi & Gq)

Perform antibody screening & characterization

Measure cytokines and biomarkers e.g. insulin

Develop custom high-throughput screens

Check out the Cisbio website to view the full range of products